Endovascular versus medical therapy in posterior cerebral artery stroke: role of baseline NIHSS and occlusion site
Davide Strambo,Patrik Michel,Thanh N. Nguyen,Mohamad Abdalkader,Muhammad M Qureshi,Daniel Strbian,Christian Herweh,Markus A Möhlenbruch,Silja Räty,Marta Olivé-Gadea,Marc Ribo,Marios-Nikos Psychogios,Urs Fischer,Anh Nguyen,Joji B. Kuramatsu,David Haupenthal,Martin Köhrmann,Cornelius Deuschl,Jordi Kühne Escolà,Jelle Demeestere,Robin Lemmens,Lieselotte Vandewalle,Shadi Yaghi,Liqi Shu,Volker Puetz,Daniel P.O. Kaiser,Johannes Kaesmacher,Adnan Mujanovic,Dominique Cornelius Marterstock,Tobias Engelhorn,Manuel Requena,Hormuzdiyar H Dasenbrock,Piers Klein,Diogo C Haussen,Mahmoud H Mohammaden,Hend Abdelhamid,Lorena Souza Viana,Bruno Cunha,Isabel R Fragata,Michele Romoli,Francesco Diana,Wei Hu,Chao Zhang,Pekka Virtanen,Riikka Lauha,Jessica Jesser,Judith Clark,Stavros Matsoukas,Johanna T Fifi,Sunil A. Sheth,Sergio Salazar-Marioni,João Pedro Marto,João Nuno Ramos,Milena Miszczuk,Christoph Riegler,Sven Poli,Khouloud Poli,Ashutosh P Jadhav,Shashvat M Desai,Volker Maus,Maximilian Kaeder,Adnan H Siddiqui,Andre Monteiro,Hesham E Masoud,Neil Suryadevara,Maxim Mokin,Shail Thanki,Kemal Alpay,Pauli Ylikotila,James E. Siegler,Italo Linfante,Guilherme Dabus,Negar Asdaghi,Vasu Saini,Christian H Nolte,Eberhard Siebert,Bettina L. Serrallach,Charlotte Sabine Weyland,Uta Hanning,Lukas Meyer,Anne Berberich,Peter Arthur Ringleb,Raul G. Nogueira,Simon Nagel
DOI: https://doi.org/10.1161/strokeaha.124.047383
IF: 10.17
2024-05-18
Stroke
Abstract:Stroke, Ahead of Print. Background:Acute ischemic stroke (AIS) with isolated posterior cerebral artery occlusion (iPCAO) lacks management evidence from randomized trials. We aimed to evaluate whether the association between endovascular treatment (EVT) and outcomes in iPCAO-AIS is modified by initial stroke severity (baseline NIHSS) and arterial occlusion site.Methods:Based on the multicenter, retrospective, case-control study of consecutive iPCAO-AIS patients (PLATO study), we assessed the heterogeneity of EVT outcomes compared to medical management (MM) for iPCAO, according to baseline NIHSS (≤6 vs. >6) and occlusion site (P1 vs. P2), using multivariable regression modelling with interaction terms. The primary outcome was the favorable shift of 3-month mRS. Secondary outcomes included excellent outcome (mRS 0-1), functional independence (mRS 0-2), symptomatic intracranial hemorrhage (sICH) and mortality.Results:From 1344 patients assessed for eligibility, 1,059 were included (median age 74 years, 43.7% women, 41.3% had intravenous thrombolysis), 364 receiving EVT and 695 MM. Baseline stroke severity did not modify the association of EVT with 3-month mRS distribution (pint=0.312), but did with functional independence (pint=0.010), with a similar trend on excellent outcome (pint=0.069). EVT was associated with more favorable outcomes than MM in patients with baseline NIHSS>6 (mRS 0-1: 30.6% vs. 17.7%, aOR=2.01, 95%CI=1.22-3.31; mRS 0-2: 46.1% vs. 31.9%, aOR=1.64, 95%CI=1.08-2.51), but not in those with NIHSS≤6 (mRS 0-1: 43.8% vs. 46.3%, aOR=0.90, 95%CI=0.49-1.64; mRS 0-2: 65.3% vs. 74.3%, aOR=0.55, 95%CI=0.30-1.0). EVT was associated with more sICH regardless of baseline NIHSS (pint=0.467), while the mortality increase was more pronounced in patients with NIHSS≤6 (pint=0.044, NIHSS≤6: aOR=7.95,95%CI=3.11-20.28, NIHSS>6: aOR=1.98,95%CI=1.08-3.65). Arterial occlusion site did not modify the association of EVT with outcomes compared to MM.Conclusion:Baseline clinical stroke severity, rather than the occlusion site, may be an important modifier of the association between EVT and outcomes in iPCAO. Only severely affected patients with iPCAO (NIHSS>6) had more favorable disability outcomes with EVT than MM, despite increased mortality and sICH.
peripheral vascular disease,clinical neurology